Twist Bioscience (TWST) shares rose after Artisan Mid Cap Fund cited the company's growth in DNA demand driven by AI and pharmaceuticals.
Twist Bioscience (TWST) shares rose after Artisan Mid Cap Fund named it a significant contributor in its Q2 investor letter, noting the company benefits from the growing demand for DNA synthesis and data generation in the AI and pharmaceutical sectors. The fund reduced some of its position in the stock during Q2 due to its strong performance.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
MOOLAH Coin: A BEP20 Token on BNB Chain and Its Trading Guide
-
2
1SWAP Token: Project Status, Historical Review, and Market Analysis
-
3
China's Cryptocurrency Regulatory Landscape and the Global Exchange Ecosystem
-
4
KENSHI (KNS) Analysis: Web3 Data Platform and Its Trading Status
-
5
DCN (Dentacoin) Value Analysis: Is It Worth Long-Term Investment?
-
6
Zeus Network (ZEUS) Token Analysis and Trading Status
-
7
ELA Coin (Elastos) Status and Historical Review: 2023-2025 Forecasts and Actual Performance
-
8
IMMO Coin Analysis: What is ImmortalDAO Finance (IMMO) and Where to Trade It
-
9
BNT Coin: Total Supply and Current Status Analysis
-
10
Mainstream Decentralized Exchanges and Apps Overview
Markets Today
Recommended Reading












